Unmasking the Silent Struggle: Sleep Experts Address the Chronic Insomnia Epidemic on November 7, 2026 Posted by
Harmony Biosciences Announces Strategic Leadership Transition: Peter Anastasiou to Succeed Dr. Jeffrey M. Dayno as CEO on November 7, 2026 Posted by
Safety Scrutiny Intensifies: Novartis Reports New Tumor Cases Linked to Zolgensma on November 7, 2026 Posted by
The End of a Scientific Debate: AAV Gene Therapies and the Emerging Cancer Risk on November 7, 2026 Posted by
Executive Moves: Sarah Browne Joins MetaVia as Chief Medical Officer Amidst a Shifting Biopharma Landscape on November 7, 2026 Posted by
Unmasking the Silent Struggle: Sleep Experts Address the Chronic Insomnia Epidemic on November 7, 2026 Posted by
Harmony Biosciences Announces Strategic Leadership Transition: Peter Anastasiou to Succeed Dr. Jeffrey M. Dayno as CEO on November 7, 2026 Posted by
Safety Scrutiny Intensifies: Novartis Reports New Tumor Cases Linked to Zolgensma on November 7, 2026 Posted by
Posted in Cancer Recovery Breaking the Cycle: Johns Hopkins Researchers Unveil Breakthrough Intranasal Vaccine to Combat Drug-Tolerant Tuberculosis on August 24, 2026
Posted in Cancer Recovery Breakthrough in the War on Tuberculosis: New Intranasal DNA Vaccine Targets Drug-Tolerant "Persisters" on August 5, 2026
Posted in Cancer Recovery Breaking the Cycle of Relapse: The Promise of a Novel Intranasal DNA Vaccine for Tuberculosis on July 27, 2026
Posted in Cancer Recovery Breakthrough in the Fight Against Tuberculosis: Johns Hopkins Researchers Develop Innovative Intranasal Vaccine on July 20, 2026
Posted in Cancer Recovery Breakthrough in Tuberculosis Defense: Johns Hopkins Researchers Unveil Novel Intranasal DNA Vaccine on July 13, 2026
Posted in Cancer Recovery A New Frontier in the War on Tuberculosis: Johns Hopkins Researchers Develop Innovative Intranasal DNA Vaccine on July 6, 2026
